Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer

Manik Amin, Monica Desai, Kathryn Trinkaus, Amberly Brown, Andrea Wang-Gillam, Benjamin Tan, Joel Picus, Steven Sorscher, Maureen Highkin, Kim Lears, Albert C. Lockhart

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences